Maternal Diabetes Linked to Higher Epilepsy Risk in Children

Children born to mothers with diabetes during pregnancy may face an elevated risk of developing epilepsy, according to research published this week in Pediatrics. The study, which analyzed data from over two million births in Ontario, Canada, found the highest risk among children whose mothers had type 2 diabetes. Although the absolute risk remains low, these findings underscore the importance of considering prenatal factors in the development of childhood epilepsy and potentially warrant increased monitoring of children born to mothers with diabetes.

Prenatal Diabetes and Epilepsy Risk

The retrospective study, led by biostatistician and epidemiologist Bénédicte Driollet, PhD, at McGill University, examined the health records of 2,105,553 children born in Ontario between 2002 and 2018. Researchers followed these children for a median of 10.2 years, tracking diagnoses of epilepsy. The study aimed to determine if maternal diabetes – encompassing gestational diabetes, type 1 diabetes, and type 2 diabetes – was associated with an increased risk of epilepsy in their offspring. Driollet emphasized that the findings highlight the potential role of prenatal factors in epilepsy development.

7.6% of children (160,644) were born to mothers with diabetes. Gestational diabetes was the most common form of diabetes during pregnancy (6.1%), followed by type 2 diabetes (1.2%) and type 1 diabetes (0.3%). During the follow-up period, 0.8% of children (17,853) were diagnosed with epilepsy, with half of those diagnoses occurring before the age of three.

Adjusted Risk Ratios

The analysis revealed a statistically significant association between maternal diabetes and childhood epilepsy, even after adjusting for other potential risk factors like maternal obesity and hypertension. Children whose mothers had type 2 diabetes faced the highest adjusted hazard ratio (HR) of 1.4 (95% Confidence Interval: 1.24-1.58). This means they had a 40% higher risk of developing epilepsy compared to children whose mothers did not have diabetes. The adjusted hazard ratios for type 1 diabetes and gestational diabetes were 1.32 (95% CI, 1.03-1.69) and 1.13 (95% CI, 1.06-1.20), respectively.

It’s important to note that hazard ratios represent relative risk, not absolute risk. While the risk was elevated in children born to mothers with diabetes, the overall incidence of epilepsy remained relatively low. The study did not identify a statistically significant difference in risk based on the duration of maternal diabetes, though the researchers acknowledge this may be due to limitations in the data.

Understanding the Link: Potential Mechanisms

The precise mechanisms linking maternal diabetes to childhood epilepsy remain unclear. Though, several potential pathways are being investigated. Exposure to high levels of glucose in utero may disrupt fetal brain development, potentially leading to altered neuronal excitability and increased susceptibility to seizures. Inflammation and oxidative stress, both common features of diabetes, could similarly contribute to neurological damage. Prenatal factors are increasingly recognized as playing a role in neurodevelopmental outcomes.

Driollet and her team acknowledge that this study establishes an association, but does not prove causation. Other factors, such as genetic predisposition and environmental influences, likely also contribute to the development of epilepsy. Further research is needed to disentangle these complex interactions.

Study Limitations and Considerations

The researchers emphasize several limitations of their study. The retrospective nature of the study means that data on potential confounding factors were not always available. The study population was limited to children born in Ontario, Canada, which may limit the generalizability of the findings to other populations. The study relied on diagnostic codes for epilepsy, which may be subject to inaccuracies. The study also did not have detailed information on glycemic control during pregnancy, which could influence the risk of epilepsy in children.

Implications for Clinical Practice and Future Research

While the findings do not warrant a change in clinical guidelines at this time, they suggest that children born to mothers with diabetes may benefit from increased vigilance for early signs of epilepsy. Early diagnosis and intervention are crucial for managing epilepsy and improving outcomes.

Driollet suggests that future research should focus on identifying specific biomarkers that could predict epilepsy risk in children born to mothers with diabetes. Investigating the role of glycemic control during pregnancy and the timing of exposure to high glucose levels could also provide valuable insights. Studies are needed to explore potential preventative strategies, such as optimizing maternal diabetes management during pregnancy.

The U.S. Centers for Disease Control and Prevention (CDC) provides comprehensive information on diabetes during pregnancy, including recommendations for preconception care and management during gestation. The American Epilepsy Foundation also offers resources for families affected by epilepsy: https://www.epilepsy.com/.

Looking ahead, continued surveillance and research will be essential to refine our understanding of the complex interplay between maternal health and childhood neurological development. This study serves as a reminder of the lasting impact of prenatal exposures and the importance of comprehensive care for both mothers and children.